Have a feature idea you'd love to see implemented?
Let us know!
DARE Dare Bioscience Inc
Price (delayed)
$3.26
Market cap
$27.86M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.11
Enterprise value
$12.49M
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse
Highlights
The equity has soared by 198% YoY and by 124% from the previous quarter
The company's quick ratio has surged by 118% YoY
Key stats
What are the main financial stats of DARE
Market
Valuations
Earnings
Shares outstanding
8.55M
Market cap
$27.86M
Enterprise value
$12.49M
Price to earnings (P/E)
N/A
Price to book (P/B)
10.28
Price to sales (P/S)
9.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.4
Revenue
$2.84M
EBIT
-$7.2M
EBITDA
-$7.09M
Free cash flow
-$10.98M
Per share
Balance sheet
Liquidity
EPS
-$1.11
Free cash flow per share
-$1.31
Book value per share
$0.32
Revenue per share
$0.34
TBVPS
$2.81
Total assets
$23.61M
Total liabilities
$20.93M
Debt
$1.52M
Equity
$2.67M
Working capital
$6.24M
Debt to equity
0.57
Current ratio
1.43
Quick ratio
1.22
Net debt/EBITDA
2.17
Margins
Efficiency
Dividend
EBITDA margin
-249.7%
Gross margin
98.8%
Net margin
-253.6%
Operating margin
-949.1%
Return on assets
-34.7%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-79.9%
Return on sales
-253.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DARE stock price
How has the Dare Bioscience stock price performed over time
Intraday
0%
1 week
0.31%
1 month
-5.78%
1 year
-40.94%
YTD
-12.13%
QTD
0.62%
Financial performance
How have Dare Bioscience's revenue and profit performed over time
Revenue
$2.84M
Gross profit
$2.81M
Operating income
-$26.95M
Net income
-$7.2M
Gross margin
98.8%
Net margin
-253.6%
DARE's net income has surged by 82% year-on-year and by 75% since the previous quarter
The net margin has soared by 75% since the previous quarter
The company's operating income rose by 34% YoY and by 6% QoQ
The operating margin has grown by 6% from the previous quarter
Growth
What is Dare Bioscience's growth rate over time
Valuation
What is Dare Bioscience stock price valuation
P/E
N/A
P/B
10.28
P/S
9.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.4
DARE's EPS has surged by 80% year-on-year and by 71% since the previous quarter
The equity has soared by 198% YoY and by 124% from the previous quarter
The price to sales (P/S) is 52% lower than the last 4 quarters average of 20.3
Efficiency
How efficient is Dare Bioscience business performance
DARE's return on sales has surged by 75% since the previous quarter
The ROA has soared by 75% from the previous quarter and by 68% YoY
Dividends
What is DARE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DARE.
Financial health
How did Dare Bioscience financials performed over time
The total assets is 13% more than the total liabilities
The current ratio has soared by 155% from the previous quarter and by 59% YoY
The company's quick ratio has surged by 118% YoY
The debt is 43% smaller than the equity
The equity has soared by 198% YoY and by 124% from the previous quarter
The debt has declined by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.